Who owns PYXIS ONCOLOGY INC?
- Ticker: PYXS
- CUSIP Number: 747324101
Tip: Access positions for across all investors
Analyze quarterly positions in Pyxis Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pyxis Oncology stock
Who bought or sold PYXIS ONCOLOGY INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Pfizer | 7.0M | $8.1M | 0% | Dec 2025 |
|
| Laurion Capital Management | 4.8M | $5.5M | 32% | Dec 2025 |
|
| Vanguard Group | 2.3M | $2.7M | 8% | Dec 2025 |
|
| Perceptive Advisors | 1.2M | $2.6M | 100% | Sep 2025 |
|
| Palo Alto Investors | 1.0M | $2.3M | 0% | Sep 2025 |
|
| 683 Capital Management | 892k | $1.0M | 70% | Dec 2025 |
|
| Millennium Management | 815k | $1.8M | -77% | Sep 2025 |
|
| Jane Street | 786k | $904k | 159% | Dec 2025 |
|
| BlackRock | 784k | $902k | 15% | Dec 2025 |
|
| Renaissance Technologies | 728k | $838k | 26% | Dec 2025 |
|
| HealthInvest Partners AB | 617k | $710k | 100% | Dec 2025 |
|
| Geode Capital Management | 577k | $664k | 6% | Dec 2025 |
|
| Driehaus Capital Management | 419k | $929k | 100% | Sep 2025 |
|
| UBS Group | 393k | $452k | 5% | Dec 2025 |
|
| Marshall Wace | 390k | $448k | 100% | Dec 2025 |
|
| Citadel Advisors | 337k | $749k | 100% | Sep 2025 |
|
| Decheng Capital | 327k | $376k | 0% | Dec 2025 |
|
| ExodusPoint Capital Management | 318k | $365k | 100% | Dec 2025 |
|
| XTX Topco | 289k | $332k | 1533% | Dec 2025 |
|
| Susquehanna International | 289k | $332k | 82% | Dec 2025 |
|
| State Street Corporation | 242k | $278k | 20% | Dec 2025 |
|
| Point72 Asset Management | 188k | $216k | 100% | Dec 2025 |
|
| Graham Capital Management | 184k | $212k | 100% | Dec 2025 |
|
| Bank of New York Mellon | 165k | $190k | 0% | Dec 2025 |
|
| Qube Research & Technologies | 146k | $168k | 373% | Dec 2025 |
|
| NewEdge Wealth | 116k | $133k | 0% | Dec 2025 |
|
| Northern Trust | 102k | $117k | 1% | Dec 2025 |
|
| Quadrature Capital | 101k | $116k | 100% | Dec 2025 |
|
| Goldman Sachs Group | 86k | $99k | -31% | Dec 2025 |
|
| Royal Bank of Canada | 78k | $0 | -10% | Sep 2025 |
|
| Bridgeway Capital Management | 77k | $170k | -46% | Sep 2025 |
|
| OMERS Administration Corporation | 67k | $77k | 100% | Dec 2025 |
|
| Cable Car Capital | 62k | $71k | 0% | Dec 2025 |
|
| Barclays | 60k | $69k | 1939% | Dec 2025 |
|
| Two Sigma Advisers | 53k | $117k | 100% | Sep 2025 |
|
| Dimensional Fund Advisors | 50k | $58k | 37% | Dec 2025 |
|
| University Of Chicago | 49k | $56k | 0% | Dec 2025 |
|
| Two Sigma Investments | 47k | $103k | 100% | Sep 2025 |
|
| Velan Capital Investment Management | 40k | $46k | -27% | Dec 2025 |
|
| Commonwealth Equity Services | 40k | $46k | -35% | Dec 2025 |
|
| Hrt Financial | 40k | $45k | 157% | Dec 2025 |
|
| LPL Financial | 35k | $40k | 151% | Dec 2025 |
|
| Cubist Systematic Strategies | 33k | $73k | 100% | Sep 2025 |
|
| American Century Companies | 32k | $37k | 100% | Dec 2025 |
|
| Lighthouse Investment Partners | 29k | $33k | 100% | Dec 2025 |
|
| Avanza Fonder AB | 27k | $31k | 100% | Dec 2025 |
|
| Cetera Investment Advisers | 27k | $31k | -2% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 24k | $28k | 1314% | Dec 2025 |
|
| Engineers Gate Manager | 23k | $26k | 100% | Dec 2025 |
|
| Fox Run Management | 23k | $26k | 100% | Dec 2025 |
|
| Maia Wealth | 22k | $30k | 100% | Dec 2025 |
|
| Point72 Asia | 18k | $40k | -6% | Sep 2025 |
|
| Advisor Group Holdings | 17k | $20k | 13% | Dec 2025 |
|
| Leucadia National Corporation | 16k | $18k | 100% | Dec 2025 |
|
| FMR | 16k | $34k | -84% | Sep 2025 |
|
| AQR Capital Management | 14k | $28k | -84% | Sep 2025 |
|
| Paces Ferry Wealth Advisors | 11k | $13k | 100% | Dec 2025 |
|
| Tower Research Capital | 11k | $12k | -17% | Dec 2025 |
|
| Goss Wealth Management | 10k | $12k | 4000% | Dec 2025 |
|
| China Universal Asset Management | 10k | $12k | -7% | Dec 2025 |
|
| Simplex Trading | 9.8k | $11k | 32% | Dec 2025 |
|
| Winthrop Capital Management | 6.0k | $7.0k | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 4.5k | $10k | 100% | Sep 2025 |
|
| Mirae Asset Global Investments | 3.0k | $3.5k | 26% | Dec 2025 |
|
| Wells Fargo & Company | 2.3k | $2.6k | 702% | Dec 2025 |
|
| Federated Investors | 1.9k | $2.2k | 100% | Dec 2025 |
|
| Gf Fund Management | 1.3k | $1.5k | -4% | Dec 2025 |
|
| NISA Investment Advisors | 961.00 | $1.1k | 0% | Dec 2025 |
|
| UMA Financial Services | 943.00 | $1.1k | 0% | Dec 2025 |
|
| Jones Financial Companies, L.L | 500.00 | $575.000000 | 0% | Dec 2025 |
|
| Us Bancorp | 94.00 | $107.996600 | 100% | Dec 2025 |
|
| CWM | 70.00 | $0 | -83% | Dec 2025 |
|
| SRS Capital Advisors | 14.00 | $16.000600 | 0% | Dec 2025 |
|
| Northwestern Mutual Wealth Management Company | 12.00 | $14.000400 | 0% | Dec 2025 |
|
| SBI Securities | 1.00 | $1.000000 | -50% | Dec 2025 |
|
Who sold out of Pyxis Oncology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tang Capital Management | Sep 2025 | 2.5M | $5.6M |
| Stempoint Capital | Sep 2025 | 690k | $1.5M |
| Schulhoff & Company | Sep 2025 | 275k | $611k |
| Pier 88 Investment Partners | Sep 2025 | 152k | $337k |
| Diadema Partners | Sep 2025 | 150k | $333k |
| Walleye Trading Advisors | Sep 2025 | 120k | $265k |
| Jacobs Levy Equity Management | Sep 2025 | 60k | $134k |
| Acadian Asset Management | Sep 2025 | 43k | $94k |
| Persistent Asset Partners | Sep 2025 | 35k | $77k |
| Prudential Financial | Sep 2025 | 16k | $36k |
| EverSource Wealth Advisors | Sep 2025 | 434.00 | $991.993800 |